{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:20:49Z","timestamp":1761765649349,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.4158\/ep.4.1.17","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:30:42Z","timestamp":1365204642000},"page":"17-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Androgen Replacement in the Treatment of klinefelter\u2019s Syndrome: Efficacy and Safety of a Nonscrotal Permeation-Enhanced testosterone Transdermal System"],"prefix":"10.1016","volume":"4","author":[{"given":"A. Wayne","family":"Meikle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian S.","family":"Dobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Arver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim E.","family":"Caramelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven W.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman A.","family":"Mazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.4.1.17_bb0005","first-page":"3","article-title":"The incidence and etiology of sex chromosome abnormalities in man","volume":"15","author":"Jacobs","year":"1979","journal-title":"Birth Defects."},{"key":"10.4158\/EP.4.1.17_bb0010","series-title":"Principles and Practice of Endocrinology and Metabolism","first-page":"1056","article-title":"Male hypogonadism","author":"Plymate","year":"1995"},{"key":"10.4158\/EP.4.1.17_bb0015","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jcem-2-11-615","article-title":"Syndrome characterized by gynecomastia, aspermatogenesis without aleydigism, and increased excretion of follicle-stimulating hormone","volume":"2","author":"Klinefelter","year":"1942","journal-title":"J Clin Endocrinol."},{"key":"10.4158\/EP.4.1.17_bb0020","series-title":"The Genetic Basis of Common Disease","first-page":"876","article-title":"Klinefelter\u2019s syndrome","author":"Paulsen","year":"1989"},{"key":"10.4158\/EP.4.1.17_bb0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0889-8529(18)30285-8","article-title":"The Klinefelter syndrome of testicular dysgenesis","volume":"20","author":"Schwartz","year":"1991","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.4158\/EP.4.1.17_bb0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1745-7599.1995.tb01165.x","article-title":"Klinefelter\u2019s syndrome","volume":"7","author":"Lesh","year":"1995","journal-title":"J Am Acad Nurse Pract."},{"key":"10.4158\/EP.4.1.17_bb0035","series-title":"Klinefelter\u2019s Syndrome in Childhood, Adolescence and Youth","first-page":"117","article-title":"Developmental, psychological and psychiatric findings","author":"Sorensen","year":"1987"},{"key":"10.4158\/EP.4.1.17_bb0040","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0015-0282(16)39135-X","article-title":"Clinical and therapeutic experiences with Klinefelter\u2019s syndrome","volume":"23","author":"Becker","year":"1972","journal-title":"Fertil Steril."},{"key":"10.4158\/EP.4.1.17_bb0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1399-0004.1988.tb03447.x","article-title":"Follow-up of 30 Klinefelter males treated with testosterone","volume":"33","author":"Nielsen","year":"1988","journal-title":"Clin Genet."},{"key":"10.4158\/EP.4.1.17_bb0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0889-8529(18)30072-0","article-title":"Hormonal therapy of male hypogonadism","volume":"23","author":"Matsumoto","year":"1994","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.4158\/EP.4.1.17_bb0055","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0022-5347(01)66141-X","article-title":"Improvement of sexual function in testosterone deficient men treated for 1 year with a permeation enhanced testosterone transdermal system","volume":"155","author":"Arver","year":"1996","journal-title":"J Urol."},{"key":"10.4158\/EP.4.1.17_bb0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0090-4295(96)00445-1","article-title":"Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system","volume":"49","author":"Meikle","year":"1997","journal-title":"Urology."},{"key":"10.4158\/EP.4.1.17_bb0065","first-page":"1832","article-title":"Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site\u2014a clinical research center study","volume":"81","author":"Meikle","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.4.1.17_bb0070","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00006199-198231050-00006","article-title":"Sexual functioning, health beliefs, and compliance with high blood pressure medications","volume":"31","author":"Watts","year":"1982","journal-title":"Nurs Res."},{"key":"10.4158\/EP.4.1.17_bb0075","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1210\/jcem-48-6-955","article-title":"Effects of androgen on sexual behavior in hypogonadal men","volume":"48","author":"Davidson","year":"1979","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.4.1.17_bb0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1037\/0278-6133.10.1.18","article-title":"Hostility patterns and health implications: correlates of Cook-Medley Hostility Scale scores in national survey","volume":"10","author":"Barefoot","year":"1991","journal-title":"Health Psychol."},{"key":"10.4158\/EP.4.1.17_bb0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry."},{"year":"1975","series-title":"The Affects Balance Scale","author":"Derogatis","key":"10.4158\/EP.4.1.17_bb0090"},{"key":"10.4158\/EP.4.1.17_bb0095","series-title":"Scale 7: Aggression","article-title":"Brief Manual for the Differential Personality Questionnaire (renamed Multidimensional Personality Questionnaire, DPQ)","author":"Tellegen","year":"1982"},{"year":"1962","series-title":"Growth at Adolescence","author":"Tanner","key":"10.4158\/EP.4.1.17_bb0100"},{"key":"10.4158\/EP.4.1.17_bb0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF00272390","article-title":"Follow-up 20 years later of 34 Klinefelter males with karyotype 47,XXY and 16 hypogonadal males with karyotype 46,XY","volume":"77","author":"Nielsen","year":"1987","journal-title":"Hum Genet."},{"key":"10.4158\/EP.4.1.17_bb0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1439-0272.1989.tb02467.x","article-title":"Testosterone therapy in Klinefelter\u2019s syndrome (a prolonged observation)","volume":"21","author":"Ruvalcaba","year":"1989","journal-title":"Andrologia."},{"key":"10.4158\/EP.4.1.17_bb0115","series-title":"Pulsatile Drug Delivery: Current Applications and Future Trends","first-page":"73","article-title":"Mimicking circadian pattern of testosterone and metabolite levels within an enhanced transdermal delivery system","author":"Mazer","year":"1993"},{"year":"1991","series-title":"Basic and Clinical Endocrinology","author":"Greenspan","key":"10.4158\/EP.4.1.17_bb0120"},{"key":"10.4158\/EP.4.1.17_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00019616-199605000-00007","article-title":"Transdermal testosterone delivery systems","volume":"6","author":"Cofrancesco","year":"1996","journal-title":"Endocrinologist."},{"key":"10.4158\/EP.4.1.17_bb0130","first-page":"97","article-title":"Transdermal testosterone supplementation in adolescent males with Klinefelter syndrome","volume":"39","author":"Linden","year":"1991","journal-title":"Clin Res."},{"key":"10.4158\/EP.4.1.17_bb0135","first-page":"623","article-title":"Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men","volume":"74","author":"Meikle","year":"1992","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.4.1.17_bb0140","series-title":"Pharmacology, Biology, and Clinical Applications of Androgens","first-page":"449","article-title":"Androderm: a permeation enhanced non-scrotal testosterone transdermal system for the treatment of male hypogonadism","author":"Meikle","year":"1996"},{"key":"10.4158\/EP.4.1.17_bb0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1203\/00006450-198501000-00022","article-title":"Pituitary-gonadal function in Klinefelter syndrome before and during puberty","volume":"19","author":"Salbenblatt","year":"1985","journal-title":"Pediatr Res."},{"key":"10.4158\/EP.4.1.17_bb0150","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1210\/jcem-39-5-856","article-title":"Effects of depot testosterone therapy on serum levels of luteinizing hormone and follicle-stimulating hormone in patients with Klinefelter\u2019s syndrome and hypogonadotropic eunuchoidism","volume":"39","author":"Fukutani","year":"1974","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.4.1.17_bb0155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF03347593","article-title":"Effects of pharmacological doses of testosterone and dihydrotestosterone on the hypothalamic pituitary axis function of Klinefelter patients","volume":"6","author":"Forti","year":"1983","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP.4.1.17_bb0160","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/00007611-198609000-00012","article-title":"Klinefelter\u2019s syndrome: historical background and development","volume":"79","author":"Klinefelter","year":"1986","journal-title":"South Med J."},{"key":"10.4158\/EP.4.1.17_bb0165","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0190-9622(90)70113-V","article-title":"Adverse dermatologic reactions to transdermal drug delivery systems","volume":"22","author":"Hogan","year":"1990","journal-title":"J Am Acad Dermatol."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20417318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20417318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/6HRX5987WPAVQEYG.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:17:03Z","timestamp":1761517023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20417318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["S1530891X20417318"],"URL":"https:\/\/doi.org\/10.4158\/ep.4.1.17","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[1998,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen Replacement in the Treatment of klinefelter\u2019s Syndrome: Efficacy and Safety of a Nonscrotal Permeation-Enhanced testosterone Transdermal System","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.4.1.17","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}